Journal of Vaccines & Vaccination

Journal of Vaccines & Vaccination
Open Access

ISSN: 2157-7560

+1-947-333-4405

Daniel A. Pollyea

Daniel A. Pollyea

Daniel A. Pollyea
Stanford University Cancer Center, USA

Research Interest

Investigator initiated Phase I/II clinical trial of azacitidine in combination with lenalidomide for elderly, previously untreated AML patients (PI), Characterization of the structure, function and prognostic value of the TET2 gene in myeloid malignancies.

Top